載入...
Systemic therapy of hepatocellular carcinoma: Current status and future perspectives
The management of hepatocellular carcinoma (HCC) has substantially changed in the past few decades, the introduction of novel therapies (such as sorafenib) have improved patient survival. Nevertheless, HCC remains the third most common cause of cancer-related deaths worldwide. Decision-making largel...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Baishideng Publishing Group Co., Limited
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3964381/ https://ncbi.nlm.nih.gov/pubmed/24696596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i12.3087 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|